Alcami Announces the Acquisition of Masy BioServices

ACQUISITION TO ADD 375,000 FT² GMP BIOSTORAGE AND PHARMA SUPPORT SERVICES

Alcami, a leading United States-based pharmaceutical and biotech contract development and manufacturing organization (CDMO), today announced it has entered into a definitive agreement to acquire Masy BioServices, a leading provider of GMP biostorage and pharma support services.

"The acquisition of Masy BioServices further underscores our commitment to supporting the global needs of the pharmaceutical and biotech industry, all from the United States," commented Patrick D. Walsh, Chairman and Chief Executive Officer of Alcami.

Masy operates three (3) GMP biostorage facilities in Northeast Massacheucettes, all within 1-hour of Boston and Cambridge, with a fourth facility coming online in early 2022. Temperature-controlled conditions are available for 3rd party rental storage from 70°C to -196°C. Their pharma support services include equipment calibration, large-scale validation and qualification projects, SenseAnywhere monitoring system, and equipment sales and rentals. Masy's additional pharma support service facilities are located in Hatfield, PA, Rockaway, NJ, and Raleigh, NC.

"We are thrilled to join the Alcami team," commented Steven Lane, Chief Executive Officer of Masy. "Our combined resources and capabilities will result in enhanced support for our current and future customers," added Mr. Lane.

The valued customers of Masy will gain immediate access to Alcami's comprehensive service offerings ranging from analytical development and testing to full drug product development and manufacturing, both oral solid dose and sterile fill-finish. Similarly, Alcami's valued clients will have access to Masy's available and growing GMP biostorage capacity and pharma support services.

"This is another important step in our strategic efforts to continue to add scale in attractive growth markets and deliver high-quality services to the pharmaceutical and biotech industry," added Mr. Walsh.

About Alcami:
Alcami is a contract development and manufacturing organization headquartered in North Carolina with over 40 years of experience advancing products through every stage of the development lifecycle. Leveraging four US-based scientific campuses, Alcami serves pharmaceutical and biotech companies of all sizes providing customizable and innovative solutions for analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, and environmental monitoring services. Alcami's private equity ownership includes Madison Dearborn Partners and Ampersand Capital Partners. 

About Masy Bioservices:
Masy Bioservices, founded by John and Laurie Massiello in 1984, has provided quality solutions to the life sciences community for nearly 40 years and meets rigorous qualifications for NVLAP accreditation to ISO 17025:2017 as well as ISO 9001:2015 certification. Services include calibration of primary standards and critical test equipment; validation and IQ/OQ/PQ of environmental chambers, autoclaves, and thermal warehouse mapping; and lab equipment rentals and sales. Masy has a premier cGMP biorepository, offering secure and tightly controlled temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, compounds, and medical devices.